Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I

NCT03882840 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Anti-cancer Cell Immunotherapy
T Cell and NK Cell

Interventions

BIOLOGICAL: ITNK cell therapy

Sponsor

Second Affiliated Hospital of Guangzhou Medical University

Collaborators

[object Object]